Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer

<i>Objective</i>: To identify dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters predictive of early disease progression in patients with metastatic renal cell cancer (mRCC) treated with anti-angiogenic tyrosine kinase inhibitors (TKI). <i>Methods</i>:...

Full description

Bibliographic Details
Main Authors: Jim Zhong, Ebrahim Palkhi, David L. Buckley, Fiona J. Collinson, Christy Ralph, Satinder Jagdev, Naveen S. Vasudev, Jayne Swain, Janet E. Brown, Tze Min Wah
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
tyrosine kinase inhibitor
anti-angiogenic therapy
metastatic renal cell cancer
Online Access:https://www.mdpi.com/2075-4418/11/7/1302

Internet

https://www.mdpi.com/2075-4418/11/7/1302

Similar Items